The medication works by mimicking the incretin hormone GLP-1, which enhances insulin secretion, suppresses glucagon release, slows gastric emptying (though this effect may attenuate over time), and reduces appetite through central nervous system pathways
Laboratory investigations suggest that Ac-SDKP promotes angiogenesis, supports vascular repair, and may protect bone marrow cells from toxic stressors such as chemotherapy agents
In fact, Sermorelin is often considered safer than other HGH therapies because it works with the bodys natural systems to produce HGH, as opposed to direct HGH replacement
Most patients notice appetite suppression by day 7-10, but scale weight loss typically appears weeks 2-4
Barden CJ, Wu F, Fernandez-Murray JP, Lu E, Sun S, Taylor MM, Rushton AL, Williams J, Tavasoli M, Meek A, Reddy AS, Doyle LM, Sagamanova I, Sivamuthuraman K, Boudreau RTM, Byers DM, Weaver DF, McMaster CR